Exploiting ROS and Metabolic Differences to Kill Cisplatin Resistant Lung Cancer
Oncotarget - United States
doi 10.18632/oncotarget.17568
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 2, 2017
Authors
Publisher
Impact Journals, LLC